Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-11

Clinical Trial Update: Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer

View source ↗

Summary

A KU Leuven study is recruiting to evaluate lymphedema and nocturia/nocturnal polyuria after pelvic lymph node dissection for urogenital/genitourinary cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Urogenital Cancer, Lower Limb Lymphedema | Status: RECRUITING